Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Takeda Adds Exelixis Arrow To Oncology Quiver

Jan 31 2017

• By Ian Haydock

Kidneys

Related Content

Exelixis Makes The Case For Early Filing Of Cabozantinib In Frontline Kidney Cancer

Oct 12 2016

Related Companies

Takeda Pharmaceutical Co. Ltd.

Exelixis, Inc.

ARIAD Pharmaceuticals, Inc.

Ipsen SA

Novartis AG

Ono Pharmaceutical Company, Ltd.

Bristol Myers Squibb Company

Eisai Co., Ltd.

Additional Topics

Japan Asia Pacific Commercial Deals Renal Cancer BioPharmaceutical

More from Business

More from Scrip

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window